دورية أكاديمية
أعرض في EDS

Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer.

التفاصيل البيبلوغرافية
العنوان: Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer.
المؤلفون: Ivanov YD; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Malsagova KA; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Goldaeva KV; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Kapustina SI; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Pleshakova TO; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Popov VP; Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia., Kozlov AF; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Galiullin RA; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Shumov ID; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia., Enikeev DV; Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia., Potoldykova NV; Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia., Ziborov VS; Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia., Petrov OF; Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia., Dolgoborodov AY; Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia., Glukhov AV; JSC 'Novosibirsk Plant of Semiconductor Devices with OKB', 630082 Novosibirsk, Russia., Novikov SV; Associate Printing-and-Publication Centre Technosphera, 125319 Moscow, Russia., Grabezhova VK; JSC 'Design Center for Biomicroelectronic Technologies 'Vega'', 630082 Novosibirsk, Russia., Yushkov ES; Department for Business Project Management, National Research Nuclear University 'MEPhI', 115409 Moscow, Russia., Konev VA; Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia., Kovalev OB; Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia., Archakov AI; Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia.
المصدر: Sensors (Basel, Switzerland) [Sensors (Basel)] 2023 Aug 30; Vol. 23 (17). Date of Electronic Publication: 2023 Aug 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101204366 Publication Model: Electronic Cited Medium: Internet ISSN: 1424-8220 (Electronic) Linking ISSN: 14248220 NLM ISO Abbreviation: Sensors (Basel) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, c2000-
مواضيع طبية MeSH: MicroRNAs* , Nanotubes, Carbon* , Prostatic Neoplasms*/diagnosis , Prostatic Neoplasms*/genetics , Nucleic Acids*, Aged ; Male ; Humans ; Nanotechnology
مستخلص: Prostate cancer (PC) is one of the major causes of death among elderly men. PC is often diagnosed later in progression due to asymptomatic early stages. Early detection of PC is thus crucial for effective PC treatment. The aim of this study is the simultaneous highly sensitive detection of a palette of PC-associated microRNAs (miRNAs) in human plasma samples. With this aim, a nanoribbon biosensor system based on "silicon-on-insulator" structures (SOI-NR biosensor) has been employed. In order to provide biospecific detection of the target miRNAs, the surface of individual nanoribbons has been sensitized with DNA oligonucleotide probes (oDNA probes) complementary to the target miRNAs. The lowest concentration of nucleic acids, detectable with our biosensor, has been found to be 1.1 × 10 -17 M. The successful detection of target miRNAs, isolated from real plasma samples of PC patients, has also been demonstrated. We believe that the development of highly sensitive nanotechnology-based biosensors for the detection of PC markers is a step towards personalized medicine.
References: Urology. 2015 Mar;85(3):704.e1-7. (PMID: 25733303)
Int J Cancer. 2012 Aug 1;131(3):652-61. (PMID: 22052531)
Biosensors (Basel). 2021 Jul 13;11(7):. (PMID: 34356707)
Indian J Clin Biochem. 2019 Apr;34(2):207-212. (PMID: 31092995)
Asian Pac J Cancer Prev. 2013;14(2):1057-60. (PMID: 23621186)
Int J Cancer. 2019 Apr 15;144(8):1941-1953. (PMID: 30350310)
Small. 2014 May 28;10(10):2022-8. (PMID: 24574202)
Nano Lett. 2007 Nov;7(11):3405-9. (PMID: 17914853)
World J Urol. 2007 Mar;25(1):11-7. (PMID: 17342490)
Br J Cancer. 2017 Apr 11;116(8):1002-1011. (PMID: 28278515)
Eng Life Sci. 2019 Feb 07;19(3):206-216. (PMID: 32625003)
Mol Biol Rep. 2021 Jul;48(7):5759-5773. (PMID: 34304390)
Nanoscale. 2017 Nov 16;9(44):17387-17395. (PMID: 29095457)
Biosens Bioelectron. 2019 Dec 1;145:111719. (PMID: 31563066)
J Urol. 2019 Jan;201(1):91-97. (PMID: 30577397)
ACS Omega. 2018 Aug 01;3(8):8471-8482. (PMID: 31458975)
J Mol Recognit. 2020 Apr;33(4):e2825. (PMID: 31828877)
Mol Med Rep. 2015 Feb;11(2):1435-41. (PMID: 25351256)
Int J Nanomedicine. 2017 Jul 27;12:5399-5407. (PMID: 28794631)
Biosens Bioelectron. 2018 Nov 15;119:126-133. (PMID: 30121424)
Asian J Androl. 2009 Jan;11(1):57-67. (PMID: 19050684)
J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. (PMID: 19276453)
Micromachines (Basel). 2021 Dec 18;12(12):. (PMID: 34945431)
Nano Lett. 2007 Sep;7(9):2608-12. (PMID: 17691849)
Curr Probl Cancer. 2018 May - Jun;42(3):337-343. (PMID: 29433825)
J Urol. 2001 Nov;166(5):1679-83. (PMID: 11586201)
Lab Chip. 2012 Dec 7;12(23):5104-11. (PMID: 23090136)
Prostate. 2012 Sep 15;72(13):1469-77. (PMID: 22298119)
Talanta. 2020 Mar 1;209:120595. (PMID: 31892044)
Micromachines (Basel). 2018 Dec 19;9(12):. (PMID: 30572645)
Clin Chem. 2021 Mar 31;67(4):602-609. (PMID: 33619518)
Curr Mol Pharmacol. 2021 Oct 25;14(4):559-569. (PMID: 33357209)
J Urol. 2013 Aug;190(2):419-26. (PMID: 23659877)
JAMA. 2017 Jun 27;317(24):2532-2542. (PMID: 28655021)
Eur Urol. 2009 Mar;55(3):563-74. (PMID: 19058905)
Int J Nanomedicine. 2018 Apr 24;13:2521-2530. (PMID: 29731627)
Eur Urol. 2007 Aug;52(2):430-5. (PMID: 17412489)
Nat Biotechnol. 2010 Jun;28(6):595-9. (PMID: 20495550)
Int J Oncol. 2011 Nov;39(5):1183-92. (PMID: 21769427)
Nat Nanotechnol. 2015 Sep;10(9):791-5. (PMID: 26237346)
Nanoscale Res Lett. 2016 Dec;11(1):406. (PMID: 27639579)
Nat Rev Urol. 2013 Aug;10(8):473-82. (PMID: 23712205)
Cell Physiol Biochem. 2018;50(5):1903-1915. (PMID: 30396163)
Semin Oncol. 2011 Dec;38(6):721-3. (PMID: 22082757)
Biomed Khim. 2016 May;62(4):403-10. (PMID: 27562993)
Nanomaterials (Basel). 2020 Aug 28;10(9):. (PMID: 32872181)
Biosensors (Basel). 2022 Feb 12;12(2):. (PMID: 35200375)
Sensors (Basel). 2019 Nov 29;19(23):. (PMID: 31795306)
Nat Nanotechnol. 2010 Feb;5(2):138-42. (PMID: 20010825)
Nat Biotechnol. 2005 Oct;23(10):1294-301. (PMID: 16170313)
Clin Biochem. 2016 Jan;49(1-2):79-84. (PMID: 26506115)
Biosensors (Basel). 2020 Dec 18;10(12):. (PMID: 33353197)
Clin Cancer Res. 2008 May 1;14(9):2588-92. (PMID: 18451220)
معلومات مُعتمدة: Agreement No. 075-15-2021-933, unique project ID: RF00121X0004 The Ministry of Education and Science of the Russian Federation
فهرسة مساهمة: Keywords: biomarker; microRNA; nanoribbon; prostate cancer; silicon-on-insulator
المشرفين على المادة: 0 (MicroRNAs)
0 (Nanotubes, Carbon)
0 (Nucleic Acids)
تواريخ الأحداث: Date Created: 20230909 Date Completed: 20230911 Latest Revision: 20230912
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10490786
DOI: 10.3390/s23177527
PMID: 37687982
قاعدة البيانات: MEDLINE
الوصف
تدمد:1424-8220
DOI:10.3390/s23177527